SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andersen Klaus) srt2:(2010-2014)"

Sökning: WFRF:(Andersen Klaus) > (2010-2014)

  • Resultat 1-10 av 26
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Assimes, Themistocles L., et al. (författare)
  • Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies
  • 2010
  • Ingår i: Journal of the American College of Cardiology. - : Elsevier BV. - 0735-1097. ; 56:19, s. 1552-1563
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives We sought to replicate the association between the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism (rs20455), and clinical coronary artery disease (CAD). Background Recent prospective studies suggest that carriers of the 719Arg allele in KIF6 are at increased risk of clinical CAD compared with noncarriers. Methods The KIF6 Trp719Arg polymorphism (rs20455) was genotyped in 19 case-control studies of nonfatal CAD either as part of a genome-wide association study or in a formal attempt to replicate the initial positive reports. Results A total of 17,000 cases and 39,369 controls of European descent as well as a modest number of South Asians, African Americans, Hispanics, East Asians, and admixed cases and controls were successfully genotyped. None of the 19 studies demonstrated an increased risk of CAD in carriers of the 719Arg allele compared with noncarriers. Regression analyses and fixed-effects meta-analyses ruled out with high degree of confidence an increase of >= 2% in the risk of CAD among European 719Arg carriers. We also observed no increase in the risk of CAD among 719Arg carriers in the subset of Europeans with early-onset disease (younger than 50 years of age for men and younger than 60 years of age for women) compared with similarly aged controls as well as all non-European subgroups. Conclusions The KIF6 Trp719Arg polymorphism was not associated with the risk of clinical CAD in this large replication study. (J Am Coll Cardiol 2010;56:1552-63) (C) 2010 by the American College of Cardiology Foundation
  •  
2.
  • Schunkert, Heribert, et al. (författare)
  • Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
  • 2011
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 43:4, s. 153-333
  • Tidskriftsartikel (refereegranskat)abstract
    • We performed a meta-analysis of 14 genome-wide association studies of coronary artery disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762 controls of European descent followed by genotyping of top association signals in 56,682 additional individuals. This analysis identified 13 loci newly associated with CAD at P < 5 x 10(-8) and confirmed the association of 10 of 12 previously reported CAD loci. The 13 new loci showed risk allele frequencies ranging from 0.13 to 0.91 and were associated with a 6% to 17% increase in the risk of CAD per allele. Notably, only three of the new loci showed significant association with traditional CAD risk factors and the majority lie in gene regions not previously implicated in the pathogenesis of CAD. Finally, five of the new CAD risk loci appear to have pleiotropic effects, showing strong association with various other human diseases or traits.
  •  
3.
  •  
4.
  • Andersen, Kasper, et al. (författare)
  • The C*-algebra of an affine map on the 3-torus
  • 2012
  • Ingår i: Documenta Mathematica. - 1431-0635. ; 17, s. 545-572
  • Tidskriftsartikel (refereegranskat)abstract
    • We study the C*-algebra of an affine map on a compact abelian group and give necessary and sufficient conditions for strong transitivity when the group is a torus. The structure of the C*-algebra is completely determined for all strongly transitive affine maps on a torus of dimension one, two or three.
  •  
5.
  • Bruze, Magnus, et al. (författare)
  • Patch test concentrations (doses in mg/cm(2) ) for the 12 non-mix fragrance substances regulated by European legislation.
  • 2012
  • Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873 .- 1600-0536. ; 66:3, s. 131-136
  • Tidskriftsartikel (refereegranskat)abstract
    • Background. According to EU legislation, 26 fragrance substance allergens must be labelled on cosmetic products. For 12 of them, the optimal patch test concentration/dose has not been evaluated. Objectives. To establish the optimal patch test doses in mg/cm(2) for the 12 fragrance substances that are not included in fragrance mix I or II in the European baseline patch test series. Materials and Methods. Patch testing with the 12 fragrance substances was performed in a stepwise manner encompassing up to five rounds in at least 100 dermatitis patients for each round. Before patch testing, an individual maximum concentration/dose was determined for each fragrance substance. Results. The predetermined maximum patch test concentrations/doses could be tested for all 12 fragrance substances, with no observable adverse reactions being noted. Conclusions. For each fragrance substance investigated, it is recommended that half of the maximum patch test dose (mg/cm(2) ) be used for aimed and screening patch testing.
  •  
6.
  •  
7.
  • Bråred Christensson, Johanna, 1965, et al. (författare)
  • Air-oxidized linalool: a frequent cause of fragrance contact allergy.
  • 2012
  • Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873 .- 1600-0536. ; 67:5, s. 247-259
  • Tidskriftsartikel (refereegranskat)abstract
    • Background. Linalool is a common fragrance terpene that, in pure form, is not allergenic or is a very weak allergen. However, linalool autoxidizes on air exposure, and the oxidation products can cause contact allergy. In a Swedish study, oxidized linalool 6.0% in petrolatum (pet.) gave 5% positive patch test reactions in 2500 dermatitis patients. Objectives. To investigate whether oxidized linalool 6%, with a stable concentration of the main haptens, the linalool hydroperoxides (Lin-OOHs) in pet., could be a useful tool for the detection of contact allergy in an international setting. Methods. Oxidized linalool 6.0% (Lin-OOHs 1%) pet. was tested in 2900 consecutive dermatitis patients in Denmark, the United Kingdom, Singapore, Spain, Sweden, and Australia. Results. Overall, 6.9% (range 3–13%) of the patients showed positive patch test reactions to oxidized linalool. Doubtful reactions were found in 9.2% of the patients (range 0–36%). Few irritant reactions were seen. Conclusions. In an international setting, oxidized linalool has been shown to be a common allergen. Oxidized linalool 6.0% (Lin-OOHs 1%) pet. is a useful, standardized and stable tool for the detection of contact allergy in dermatitis patients. Many patients showing positive patch test reactions to oxidized linalool would not have been informed of their fragrance allergy if this specific test had not been performed
  •  
8.
  • Bråred Christensson, Johanna, 1965, et al. (författare)
  • Positive patch test reactions to oxidized limonene: exposure and relevance
  • 2014
  • Ingår i: Contact Dermatitis. - : Wiley. - 0105-1873 .- 1600-0536. ; 71:5, s. 264-272
  • Tidskriftsartikel (refereegranskat)abstract
    • Background. R-Limonene is a common fragrance terpene found in domestic and industrial products. R-Limonene autoxidizes on air exposure, and the oxidation products can cause contact allergy. In a recent multicentre study, 5.2% (range 2.3-12.1%) of 2900 patients showed a positive patch test reaction to oxidized R-limonene. Objective. To study the exposure to limonene among consecutive dermatitis patients reacting to oxidized R-limonene in an international setting, and to assess the relevance of the exposure for the patients' dermatitis. Methods. Oxidized R-limonene 3.0% (containing limonene hydroperoxides at 0.33%) in petrolatum was tested in 2900 consecutive dermatitis patients in Australia, Denmark, the United Kingdom, Singapore, Spain, and Sweden. A questionnaire assessing exposure to limonene-containing products was completed. Results. Overall, exposure to products containing limonene was found and assessed as being probably relevant for the patients' dermatitis in 36% of the limonene-allergic patients. In Barcelona and Copenhagen, >70% of the patients were judged to have had an exposure to limonene assessed as relevant. Conclusions. Oxidized R-limonene is a common fragrance allergen, and limonene was frequently found in the labelling on the patients' products, and assessed as relevant for the patients' dermatitis. A large number of domestic and occupational sources for contact with R-limonene were identified.
  •  
9.
  • Dehlendorff, Christian, et al. (författare)
  • Analysis of computer experiments with multiple noise sources
  • 2010
  • Ingår i: Quality and Reliability Engineering International. - : Wiley. - 0748-8017 .- 1099-1638. ; 26:2, s. 137-146
  • Tidskriftsartikel (refereegranskat)abstract
    • In this paper we present a modeling framework for analyzing computermodels with two types of variations. The paper is based on a case study of an orthopedic surgical unit, which has both controllable and uncontrollable factors. Our results show that this structure of variation can be modeled effectively with linear mixed effects models and generalized additive models
  •  
10.
  • Dehlendorff, Christian, et al. (författare)
  • Conditional Value at Risk as a Measure for Waiting Time in Simulations of Hospital Units
  • 2010
  • Ingår i: Quality Technology & Quantitative Management. - : Informa UK Limited. - 1684-3703 .- 1811-4857. ; 7:3, s. 321-336
  • Tidskriftsartikel (refereegranskat)abstract
    • The utility of conditional value at risk (CVaR) of a sample of waiting times as a measure for reducing long waiting times is evaluated with special focus on patient waiting times in a hospital. CVaR is the average of the longest waiting times, i.e., a measure at the tail of the waiting time distribution. The presented results are based on a discrete event simulation (DES) model of an orthopedic surgical unit at a university hospital in Denmark. Our analysis shows that CVaR offers a highly reliable performance measure. The measure targets the longest waiting times and these are generally accepted to be the most problematic from the points of view of both the patients and the management. Moreover, CVaR can be seen as a compromise between the well known measures: average waiting time and the maximum waiting time
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 26
Typ av publikation
tidskriftsartikel (26)
Typ av innehåll
refereegranskat (25)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Andersen, Klaus E (13)
Bruze, Magnus (10)
Goossens, An (7)
White, Ian R. (7)
Goncalo, Margarida (6)
Rustemeyer, Thomas (5)
visa fler...
Johansen, Jeanne Duu ... (5)
Maibach, Howard I. (5)
Le Coz, Christophe J ... (4)
Kulahci, Murat (3)
Agner, Tove (3)
Goh, Chee Leok (3)
Nixon, Rosemary (3)
Karlberg, Ann-Theres ... (3)
Salomaa, Veikko (2)
Melander, Olle (2)
Ouwehand, Willem H. (2)
Cambien, Francois (2)
Deloukas, Panos (2)
Isaksson, Marléne (2)
Gruvberger, Birgitta (2)
Thorleifsson, Gudmar (2)
Thorsteinsdottir, Un ... (2)
Stefansson, Kari (2)
Rader, Daniel J. (2)
Wichmann, H. Erich (2)
Samani, Nilesh J. (2)
Musunuru, Kiran (2)
Anand, Sonia S (2)
Bråred Christensson, ... (2)
Svedman, Cecilia (2)
Andersen, Ken (2)
Elosua, Roberto (2)
Altshuler, David (2)
Kathiresan, Sekar (2)
Lefmann, Kim (2)
O'Donnell, Christoph ... (2)
Li, Mingyao (2)
Braund, Peter S. (2)
Balmforth, Anthony J ... (2)
Hall, Alistair S. (2)
Hengstenberg, Christ ... (2)
Schunkert, Heribert (2)
Reilly, Muredach P. (2)
Assimes, Themistocle ... (2)
Holm, Hilma (2)
Voight, Benjamin F. (2)
Erdmann, Jeanette (2)
Willenborg, Christin ... (2)
Patterson, Chris C. (2)
visa färre...
Lärosäte
Lunds universitet (18)
Göteborgs universitet (5)
Luleå tekniska universitet (3)
Karolinska Institutet (3)
Uppsala universitet (2)
Språk
Engelska (26)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (16)
Naturvetenskap (4)
Teknik (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy